The clinical diagnostic value of maternal autoantibodies against extractable nuclear antigens in fetal bradyarrhythmia
- Авторлар: Menzhinskaya I.V.1, Khodzhaeva Z.S.1, Bokeria E.L.1, Klimenchenko N.I.1, Potapova A.A.1, Van'ko L.V.1, Krechetova L.V.1, Kosheleva N.M.2
-
Мекемелер:
- V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
- V.A. Nasonova Research Institute of Rheumatology
- Шығарылым: № 7 (2020)
- Беттер: 53-60
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248846
- DOI: https://doi.org/10.18565/aig.2020.7.53-60
- ID: 248846
Дәйексөз келтіру
Аннотация
Толық мәтін
Авторлар туралы
Irina Menzhinskaya
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: i_menzinskaya@oparina4.ru
Dr.Med.Sci., Leading Researcher at the Laboratory of Clinical Immunology
Zulfiya Khodzhaeva
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: z_khodzhaeva@oparina4.ru
Khodzhaeva, Deputy Director of Obstetrics Institute
Ekaterina Bokeria
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: e_bokeriya@oparina4.ru
Dr.Med.Sci., Professor, Head of the 2nd Department of Pathology of Newborns and Premature Babies, Adviser to the Director
Natalia Klimenchenko
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: n_klimenchenko@oparina4.ru
Ph. D., Senior Researcher at the Department of Obstetric and Extragenital Pathology
Alena Potapova
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: doc.PotapovaAA@yandex.ru
Ph.D. Student
Ludmila Van'ko
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: LVanko@oparina4.ru
Dr.Med.Sci., Professor, Leading Researcher at the Laboratory of Clinical Immunology
Lubov Krechetova
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia
Email: l_krechetova@oparina4.ru
Dr.Med.Sci., Head of the Laboratory of Clinical Immunology
Nadezhda Kosheleva
V.A. Nasonova Research Institute of Rheumatology
Email: nadkosheleva@yandex.ru
Ph.D., Senior Researcher at the Laboratory of Systemic Rheumatic Diseases with a Group of Hemorheological Disorders
Әдебиет тізімі
- Ling M., Murali M. Antinuclear antibody tests. Clin. Lab. Med. 2019; 39(4): 513-24. https://dx.doi.org/10.1016/j.cll.2019.07.001.
- Vasquez-Canizares N., Wahezi D., Putterman C. Diagnostic and prognostic tests in systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 2017; 31(3): 351-63. https://dx.doi.org/10.1016/j.berh.2017.10.002.
- Кошелева Н.М., Алекберова З.С. Неонатальная волчанка. Современная ревматология. 2015; 4: 92-8.
- Ambrosi A., Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res. Ther. 2012; 14(2): 208. https://dx.doi.org/10.1186/ar3787.
- Wainwright B., Bhan R., Trad C., Cohen R., Saxena A., Buyon J., Izmirl P. Autoimmune-mediated congenital heart block. Best Pract. Res. Clin. Obstet. Gynaecol. 2020; 64: 41-51. https://dx.doi.org/10.1016/j.bpobgyn.2019.09.001.
- Бокерия Е.Л. Перинатальная кардиология: настоящее и будущее. Часть II: нарушение ритма сердца и проводимости. Российский вестник перинатологии и педиатрии. 2019; 64(4): 6-10.
- Zhou K. Y., Hua Y.M. Autoimmune-associated congenital heart block: a new insight in fetal life. Chin. Med. J. 2017; 130(23): 2863-71. https://dx.doi. org/10.4103/0366-6999.219160.
- Сафонова И.Н. Фетальные аритмии: антенальная ультразвуковая дифференциальная диагностика, прогнозирование постнатальных результатов и перинатальная практика. SonoAceUltrasound. 2014; 26: 17-29.
- Беспалова Е.Д., Суратова О.Г., Бокерия Е.Л., Бартагова М.Н., Гасанова Р.М., Тюменева А.И. Диагностика и лечение кардиальной патологии у плода. Бокерия Л.А., ред. М.: Издательство НЦССХ им. А.Н. Бакулева; 2015. 244 с.
- Brito-Zeron P., Izmirly P.M., Ramos-Casals M., Buyon J.P., Khamashta M.A. The clinical spectrum of autoimmune congenital heart block. Nat. Rev. Rheumatol. 2015; 11(5): 301-12. https://dx.doi.org/10.1038/nrrheum.2015.29.
- Jaeggi E., Laskin C., Hamilton R., Kingdom J., Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J. Am. Coll. Cardiol. 2010; 55(24): 277884. https://dx.doi.org/10.1016/jjacc.2010.02.042.
- Tonello M., Ruffatti A., Favaro M., Tison T., del Ross T., Calligaro A. et al. Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients. Lupus Sci. Med. 2016; 3(1): e000129. https://dx.doi.org/10.1136/lupus-2015-000129.
- Kan N, Silverman E.D., Kingdom J., Dutil N., Las kin C., Jaeggi E. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat. Diagn. 2017; 37(4): 375-82. https://dx.doi.org/10.1002/pd.5021.
- Lazzerini P.E., Capecchi P.L., Laghi-Pasini F. Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses. Scand. J. Immunol. 2010; 72(3): 213-22. https://dx.doi.org/10.1111/j.1365-3083.2010.02428.x.
- Brucato A, Tincani A., Fredi M., Breda S., Ramoni V., Morel N. et al. Should we treat congenital heart block with fluorinated corticosteroids? Autoimmun. Rev. 2017; 16(11): 1115-8. https://dx.doi.org/10.1016/j.autrev.2017.09.005.
- Van den Berg N.W, Slieker M.G., van Beynum I.M., Bilardo C.M., de Bruijn D., Clur S.A. et al. Fluorinated steroids do not improve outcome of isolated atrioventricular block. Int. J. Cardiol. 2016; 225: 167-71. https://dx.doi. org/10.1016/j.ijcard.2016.09.119.
- Izmirly P.M., Saxena A., Sahl S.K., Shah U., Friedman D.M., Kim M.Y. et al. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann. Rheum. Dis. 2016; 75(6): 1161-5. https://dx.doi.org/10.1136/ annrheumdis-2015-208311.
- Trucco S.M., Jaeggi E., Cuneo B., Moon-Grady A.J., Silverman E., Silverman N. et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J. Am. Coll. Cardiol. 2011; 57(6): 715-23. https://dx.doi.org/10.1016/ j.jacc.2010.09.044.
- Izmirly P.M., Kim M.Y., Llanos C., Le P.U., Guerra M.M., Askanase A.D. et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 2010; 69(10): 1827-30. https://dx.doi.org/10.1136/ard.2009.119263.
- Izmirly P.M., Costedoat-Chalumeau N., Pisoni C.N., Khamashta M.A., Kim M.Y., Saxena A. et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012; 126(1): 76-82.https://dx.doi.org/10.1161/ CIRCULATI0NAHA.111.089268.
- Martinez-Sanchez N., Perez-Pinto S., Robles-Marhuenda A., Arnalich-Fernandez F., Martin Camean M., Hueso Zalvide E., Bartha J.L. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Immunol. Res. 2017; 65(2): 487-94. https://dx.doi.org/10.1007/s12026-016-8888-5.
- Tonello M., Ruffatti A., Marson P., Tison T., Marozio L., Hoxha A. et al. Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block. Transfusion. 2015; 55(7): 1782-6. https://dx.doi.org/ 10.1111/trf.13046.
- Ruffatti A., Cerutti A., Favaro M., Del Ross T., Calligaro A., Hoxha A. et al. Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study. Clin. Exp. Rheumatol. 2016; 34(4): 706-13.